Karnataka halts inoculation for 18-44 age group due to vaccine shortage

Covid-19 vaccination drive for the 18-44 age group has been halted in Karnataka, with the state government categorically saying the vaccines for the beneficiary category are "currently not available"

Coronavirus, covid-19, vaccination, vaccine
ANI General News
2 min read Last Updated : May 23 2021 | 11:10 AM IST

COVID-19 vaccination drive for the 18-44 age group has been halted in Karnataka, with the state government categorically saying the vaccines for the beneficiary category are "currently not available".

However, the notification issued by Dr Arundhathi Chandrashekhar, director, National Health Mission (NHM), Karnataka, said the "identified state COVID front line workers, vulnerable group and priority groups" within the 18-44 years age group, will be informed of the date and time of vaccination by the designated nodal officers.

Regarding the inoculation of the 45 years and above age group, the notification said the registration for COVISHIELD vaccines will be open online in urban areas and onsite in rural areas for the first dose, and beneficiaries can walk-in to their nearest COVID vaccination center for the second dose.

Meanwhile, the state said that the COVAXIN vaccine is not currently available for the first dose of the 45 and above age group also, but the SMS will be sent to beneficiaries due for their second dose. "Beneficiaries should visit the designated COVID vaccination center mentioned in the SMS," the notification said.

Earlier, the vaccination for people below 45 years was halted on May 20 except for some categories of frontline workers.

However later, Health Minister Dr K Sudhakar had said that vaccination for people in the 18-44 age group will resume from May 22.

"State government-identified frontline workers and priority groups will be vaccinated first," he had tweeted.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus Vaccine

First Published: May 23 2021 | 11:08 AM IST

Next Story